AGP Picks
View all

Entertainment Wire Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Entertainment Wire Massachusetts.

Press releases published on September 30, 2026

CJ Biomaterials Secures BPI, TÜV AUSTRIA Certifications for New PHACT™ All-PHA Compound Designed for Home Compostable Cutlery
2026 Beijing Forum on Swift Response to Public Complaints to Open on October 12, with a Series of Research Outcomes to Be Released
Milliman and Monitaur team up to offer comprehensive AI governance solution
Townsquare Announces Conference Call To Discuss Third Quarter 2026 Results
Lee Enterprises Appoints Gregory Hoffmann to Board of Directors
Construction of Marine Energy Integration Industrial Park Gathers Pace in Qingdao
Qingdao Accelerates Development of Coastal Outdoor Sports Destination
Qingdao FTZ Selected Among China's Pilots for Autonomous Opening-Up in Standardization
Ernexa Therapeutics Reports Compelling ERNA-101 Safety Results Across Three Critical IND-Enabling Studies, Advancing Toward Planned Q4 2026 IND
Candel Therapeutics Announces Integrated Clinical and Biomarker Data That Showed Durable Local and Systemic Immune Activation after Aglatimagene Besadenovec in Intermediate-Risk Localized Prostate Cancer
Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)
Trump Media & Technology Group and TAE Technologies File Form S-4 Registration Statement for Proposed Merger
55th Annual Bob Evans Farm Festival Returns October 9-11
Candel Therapeutics Announces New Data Showing Sustained Immune Remodeling More Than Two Years After Aglatimagene Besadenovec Treatment in Localized Prostate Cancer at ASTRO 2026
IBN Announces Latest Episode of The BioMedWire Podcast Featuring the Return of Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
Rezera Announces Phase 1 Results for Trabzanoflast, which was Generally Well Tolerated and Demonstrated High Central Nervous System Exposure (CNS)
Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development
AI Visibility for Industrial Automation Companies Averages 4% Across the Top 100 Vendors, Benchmark Finds
Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026
 GDEV announces final results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Entertainment Wire Massachusetts

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.